Gefitinib Impurity VII | CAS 179688-53-0 - Request Quote
Gefitinib Impurity VII
| SZ CAT No: | SZ-G018016 |
| CAS No | 179688-53-0 |
| Mol.F. | C11H10N2O4 |
| Mol.Wt. | 234.2 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Gefitinib Impurity VII is chemically 7-Methoxy-4-oxo-1,4-dihydroquinazolin-6-yl acetate. Gefitinib Impurity VII is supplied with detailed characterization data compliant with regulatory guideline. Gefitinib Impurity VII can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gefitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 179688-53-0
Purchase 179688-53-0
Order 179688-53-0
Enquire 179688-53-0
price of 179688-53-0
179688-53-0 Supplier
179688-53-0 Manufacturer
179688-53-0 Exporter
buy high quality Gefitinib Impurity VII
Purchase Gefitinib Impurity VII
Gefitinib Impurity VII suppliers
Gefitinib Impurity VII manufacturers
Gefitinib Impurity VII price
Order Gefitinib Impurity VII
Enquire Gefitinib Impurity VII
Gefitinib Impurity VII cost
Gefitinib Impurity VII Supplier
Gefitinib Impurity VII Distributor
Gefitinib Impurity VII for Method Validation
Gefitinib Reference Standard
Gefitinib Impurity VII for ANDA Filing
Gefitinib Impurity VII for Forced Degradation Studies
Gefitinib Impurity VII Identification Standards
Gefitinib Impurity VII for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.